Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neurocrine Biosciences (NBIX) Debt Ratio (2018 - 2024)

Historic Debt Ratio for Neurocrine Biosciences (NBIX) over the last 5 years, with Q1 2024 value amounting to 0.04.

  • Neurocrine Biosciences' Debt Ratio changed N/A to 0.04 in Q1 2024 from the same period last year, while for Mar 2024 it was 0.04, marking a year-over-year change of. This contributed to the annual value of 0.05 for FY2023, which is N/A changed from last year.
  • As of Q1 2024, Neurocrine Biosciences' Debt Ratio stood at 0.04.
  • Neurocrine Biosciences' Debt Ratio's 5-year high stood at 0.28 during Q3 2020, with a 5-year trough of 0.04 in Q1 2024.
  • Its 3-year average for Debt Ratio is 0.13, with a median of 0.06 in 2023.